International Flavors & Fragrances Stock (US4595061015): Jefferies Raises Price Target to $105 on Strong Q1 2026 Beat and Reaffirmed 2026 Guidance, 05/ 07/ 2026
08.05.2026 - 20:11:16 | ad-hoc-news.deInternational Flavors & Fragrances stock surged after Jefferies raised its price target to $105, citing a strong Q1 2026 earnings beat and reaffirmed 2026 guidance.
Shares of International Flavors & Fragrances Inc. (NYSE: IFF) jumped over 17% in morning trading on Thursday, May 7, 2026, reaching $83.21, driven by a robust Q1 2026 earnings report that beat analyst expectations and reaffirmed the company's 2026 targets, according to Investing.com. The specialty chemicals company reported net income attributable to shareholders of $169 million, or $0.66 per share, compared with a net loss of $1,018 million a year earlier that included a large goodwill impairment, as detailed in the company's 10-Q filing with the SEC. Net sales were $2.741 billion, down 4% on a reported basis, but up 3% on a comparable currency-neutral basis, with divestitures reducing sales by about $289 million, according to Stock Titan.
As of: 05/08/2026
By the AD HOC NEWS Editorial Team – Equity Coverage.
At a Glance
- Name: IFF
- ISIN: US4595061015
- Sector/Industry: Specialty Chemicals
- Headquarters/Country: United States
- Core Markets: Food and Beverage, Personal Care, Household Goods, Pharmaceuticals
- Key Revenue Drivers: Flavors, Fragrances, Cosmetic Actives, Nutritional Lipids
- Primary Exchange: NYSE
- Trading Currency: USD
- CEO: Nicolas Hieronimus (start date: 01/01/2023)
- Last Quarterly Results: Q1 2026 net income of $169M on $2.741B in sales, up 3% on a comparable currency-neutral basis, with Adjusted Operating EBITDA margin of 20.7%, according to Stock Titan, 05/07/2026
- Next Earnings Date: Q2 2026 earnings call scheduled for 08/05/2026 at 8:00 AM ET, per company IR release, 05/07/2026
- Current Guidance: Reaffirmed 2026 targets with revenue growth of 2-4% on a comparable basis and Adjusted Operating EBITDA margin of 20-21%, per company press release, 05/07/2026
- Dividend: $0.40 per share quarterly, last ex-date 05/01/2026, per company IR release, 05/07/2026
- Analyst Consensus: Average price target of $90.99 with 12 Buy and 5 Hold ratings, per MarketBeat, 05/08/2026
How International Flavors & Fragrances Makes Money: The Core Business Model
International Flavors & Fragrances generates revenue through the creation and production of flavors, fragrances, cosmetic actives, and nutritional lipids for a wide array of end markets, including food and beverage, personal care, household goods, and pharmaceutical products, according to the company's profile on MarketBeat. The company develops taste and scent solutions that are sold to global consumer goods manufacturers, leveraging its extensive portfolio of proprietary ingredients and technologies. Revenue is derived from product sales, licensing agreements, and custom formulation services, with a focus on high-margin specialty ingredients.
In Q1 2026, the company reported net sales of $2.741 billion, down 4% on a reported basis but up 3% on a comparable currency-neutral basis, reflecting underlying growth in core segments despite divestitures that reduced sales by about $289 million, as per Stock Titan. The business had revenue of $2.74 billion during the quarter, compared to analyst estimates of $2.64 billion, according to MarketBeat. This growth was driven by volume increases and productivity gains under the IFF Productivity Program, which improved Adjusted Operating EBITDA margin to 20.7% from 20.3% in the prior year, as detailed in the 10-Q filing.
International Flavors & Fragrances's Key Revenue and Product Drivers
The company's key revenue drivers include its Taste, Food Ingredients, and Health & Biosciences segments, each of which posted higher sales and Adjusted Operating EBITDA in Q1 2026, aided by volume growth and productivity efforts, according to Stock Titan. Taste segment sales grew on a comparable basis, driven by demand for flavor solutions in food and beverage applications, while Food Ingredients benefited from increased sales of specialty ingredients for dairy and bakery products. Health & Biosciences saw growth in nutritional lipids and cosmetic actives, reflecting strong demand in personal care and pharmaceutical markets.
Operating cash flow strengthened to $257 million in Q1 2026, supporting $165 million of capital expenditures, $35 million of share repurchases, and $102 million in dividends, as reported in the 10-Q filing. Total debt edged down to $5.817 billion, with interest expense falling to $44 million, indicating improved balance sheet health. The company continues to incur regulatory and legal costs tied to fragrance competition matters and other proceedings, which could influence future expenses depending on outcomes disclosed in subsequent periods, as noted in the filing.
Industry Trends and Competitive Landscape
The specialty chemicals industry is characterized by innovation-driven growth, with companies like International Flavors & Fragrances competing on product differentiation, sustainability, and cost efficiency. Peers in the identical product segment include Givaudan SA (GIVN.SW), Firmenich SA (FMN.SW), and Symrise AG (SY1.DE), all of which are publicly traded and operate in flavors and fragrances, according to their annual reports. These companies face similar trends, including rising demand for natural and sustainable ingredients, regulatory scrutiny, and consolidation in the sector.
Market size for the global flavors and fragrances market is projected to grow at a compound annual growth rate of 5-7% through 2030, driven by increasing consumer demand for premium and functional products, according to Statista. International Flavors & Fragrances is well-positioned to benefit from this growth, given its diversified portfolio and global footprint. However, competition remains intense, with peers investing heavily in R&D and sustainability initiatives to maintain market share.
Why International Flavors & Fragrances Matters to US Investors
International Flavors & Fragrances is listed on the NYSE and trades in USD, making it accessible to US investors seeking exposure to the specialty chemicals sector. The company has a twelve-month low of $59.14 and a twelve-month high of $84.45, with shares trading up $1.09 during trading hours on Thursday, reaching $79.35, according to MarketBeat. Institutional investors own 96.02% of the company's stock, indicating strong professional interest.
The stock surged 17.58% in morning trading on Thursday, May 7, 2026, to $83.21, driven by the Q1 2026 earnings beat and Jefferies' price target increase to $105, signaling strong upside potential, as reported by Investing.com. This move reflects investor optimism around the company's outlook and reaffirmed 2026 targets. US investors should note the company's exposure to global markets, which introduces currency risk, but the USD-denominated listing provides a hedge for domestic portfolios.
Which Investor Profile Fits International Flavors & Fragrances – and Which Does Not?
International Flavors & Fragrances may appeal to growth-oriented investors seeking exposure to a specialty chemicals company with a diversified portfolio and strong cash flow generation. The company's focus on innovation and sustainability aligns with long-term trends in consumer goods, making it suitable for investors with a multi-year horizon. However, the stock's volatility, as evidenced by the 17.58% surge, may not suit risk-averse investors or those seeking stable income.
Investors should also consider the company's regulatory and legal risks, including ongoing fragrance competition matters, which could impact future earnings. Peers like Givaudan, Firmenich, and Symrise offer similar exposure but with different risk profiles, so diversification within the sector may be prudent. Overall, International Flavors & Fragrances fits investors comfortable with moderate volatility and sector-specific risks.
What Analysts Are Saying About International Flavors & Fragrances Stock
Analyst sentiment on International Flavors & Fragrances is positive, with multiple firms raising price targets following the Q1 2026 earnings beat. Jefferies Financial Group increased its target price from $97.00 to $105.00, signaling strong upside potential, according to MarketBeat. BNP Paribas Exane raised its price objective from $85.00 to $95.00, while Wells Fargo & Company increased its target from $85.00 to $100.00 with an overweight rating, as reported by MarketBeat.
Analyst Ratings & Research
Risks and Open Questions for International Flavors & Fragrances
Key risks for International Flavors & Fragrances include regulatory and legal challenges, particularly in fragrance competition matters, which could lead to increased expenses or penalties. The company also faces currency fluctuations, given its global operations, and potential demand volatility in end markets like food and beverage and personal care. Additionally, divestitures have impacted reported sales, and future strategic moves could affect growth trajectories.
Open questions include the resolution of ongoing legal proceedings and their financial impact, as well as the company's ability to sustain margin improvements amid rising input costs. Investors should monitor Q2 2026 results and guidance updates for further clarity on these issues.
Key Events and Outlook for Investors
Investors should watch the Q2 2026 earnings call scheduled for 08/05/2026 at 8:00 AM ET, where management will provide updates on performance and guidance, per the company's IR release. The company has reaffirmed its 2026 targets, with revenue growth of 2-4% on a comparable basis and Adjusted Operating EBITDA margin of 20-21%, indicating confidence in underlying growth.
What to Watch Next
- 08/05/2026: Q2 2026 earnings call and guidance update
- 11/05/2026: Q3 2026 earnings call
- 02/05/2027: Q4 2026 earnings call and full-year 2027 guidance
Conclusion
International Flavors & Fragrances stock surged after Jefferies raised its price target to $105, driven by a strong Q1 2026 earnings beat and reaffirmed 2026 guidance. The company reported net income of $169 million on $2.741 billion in sales, with underlying growth of 3% on a comparable currency-neutral basis and improved margins. Analysts remain optimistic, with an average price target of $90.99 and a moderate buy consensus, reflecting confidence in the company's outlook. However, investors should consider regulatory and legal risks and monitor upcoming earnings calls for further updates.
Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.
So schätzen die Börsenprofis IFF Aktien ein!
FĂĽr. Immer. Kostenlos.
